Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286776 · ClinicalTrials.gov registry record · NA
Memory Retrieval and Encoding Investigated by Neural Stimulation
A NA study of Epilepsy Intractable, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 11
- Study locations
NCT04286776: Active NA study of Epilepsy Intractable, sponsored by University of Pennsylvania.
NCT04286776 is a NA study of Epilepsy Intractable that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 800 participants, above the 119-participant average among 3 other Epilepsy Intractable trials with a reported enrollment target (572% higher). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04286776, a NA study of Epilepsy Intractable, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this research is to understand biomarkers of human memory through correlational analyses and to use focal electrical stimulation as a causal manipulation to understand how biomarkers of memory relate to other brain states and behavioral measures.
Primary Outcome
1\. We will use linear mixed effects models and L2-penalized logistic regression classifiers to compare periods of successful and unsuccessful performance in our tasks
Conditions Studied
Interventions
- DEVICE Direct electrical stimulation
Study Locations (11)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Thomas Jefferson University Hospital - Philadelphia
Texas
- UT Southwestern Medical Center - Dallas
- University of Texas Health Science Center at San Antonio - San Antonio
Colorado
- University of Colorado, Denver - Aurora
Georgia
- Emory University Hospital - Atlanta
Maryland
- National Institute of Neurological Disorders and Stroke - Bethesda
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- Mayo Clinic - Rochester
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2014-10-12 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the registry record for NCT04286776 still lists
NCT04286776 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 119-participant average among 3 other Epilepsy Intractable trials with a reported enrollment target (572% higher).
The record links to 1 condition, with Epilepsy Intractable appearing as the primary indexed condition, and to 1 intervention - of which Direct electrical stimulation is the first listed.
NCT04286776 lists 11 locations in 9 states (Pennsylvania, Texas, Colorado).
Frequently Asked Questions
What is clinical trial NCT04286776 about?
NCT04286776 is a clinical study titled "Memory Retrieval and Encoding Investigated by Neural Stimulation". The purpose of this research is to understand biomarkers of human memory through correlational analyses and to use focal electrical stimulation as a causal manipulation to understand how biomarkers of memory relate to other brain states and behavioral measures.
What is the current status of trial NCT04286776?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2014-10-12. Estimated completion is 2024-12-31.
What conditions does trial NCT04286776 study?
This clinical trial studies the following conditions: Epilepsy Intractable.
What interventions are being tested in trial NCT04286776?
The interventions under investigation include: Direct electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT04286776?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04286776 being conducted?
This trial has 11 study locations across Colorado, Georgia, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy Intractable
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neural Mechanisms of Spatial Representations Beyond the Self
RECRUITING · NA
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
-
Localizing Epileptic Networks Using MRI and iEEG
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI